Advertisement
Research Article

Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica

  • Rolando Herrero mail,

    herreror@iarc.fr

    Affiliation: Prevention and Implementation Group, International Agency for Research on Cancer, Lyon, France

    X
  • Wim Quint,

    Affiliation: DDL Diagnostic Laboratory, Rijswijk, The Netherlands

    X
  • Allan Hildesheim,

    Affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Paula Gonzalez,

    Affiliation: Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, Guanacaste, Costa Rica

    X
  • Linda Struijk,

    Affiliation: DDL Diagnostic Laboratory, Rijswijk, The Netherlands

    X
  • Hormuzd A. Katki,

    Affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Carolina Porras,

    Affiliation: Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, Guanacaste, Costa Rica

    X
  • Mark Schiffman,

    Affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Ana Cecilia Rodriguez,

    Affiliation: Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, Guanacaste, Costa Rica

    X
  • Diane Solomon,

    Affiliation: Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Silvia Jimenez,

    Affiliation: Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, Guanacaste, Costa Rica

    X
  • John T. Schiller,

    Affiliation: Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Douglas R. Lowy,

    Affiliation: Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Leen-Jan van Doorn,

    Affiliation: DDL Diagnostic Laboratory, Rijswijk, The Netherlands

    X
  • Sholom Wacholder,

    Affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Aimée R. Kreimer,

    Affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • for the CVT Vaccine Group

    Membership of the CVT Vaccine Group is provided in the Acknowledgments

    X
  • Published: July 17, 2013
  • DOI: 10.1371/journal.pone.0068329

Reader Comments (1)

Post a new comment on this article